Controlled release of carnosine from poly(lactic-co-glycolic acid) beads using nanomechanical magnetic trigger towards the treatment of glioblastoma

Tools

Habra, K. ORCID: 0000-0001-8272-6048, Morris, R.H. ORCID: 0000-0001-5511-3457, Mcardle, S.E.B. ORCID: 0000-0001-6929-9782 and Cave, G.W.V. ORCID: 0000-0002-4167-1332, 2022. Controlled release of carnosine from poly(lactic-co-glycolic acid) beads using nanomechanical magnetic trigger towards the treatment of glioblastoma. Nanoscale Advances. ISSN 2516-0230

Preview

Text
1542305_Cave.pdf - Published version
Download (1MB) | Preview

Official URL: https://doi.org/10.1039/d2na00032f

Abstract

Nanometer scale rods of superparamagnetic iron oxide have been encapsulated, along with the anti-cancer therapeutic carnosine, inside porous poly(lactic-co-glycolic acid) microbeads with a uniform morphology, synthesised using microfluidic arrays. The sustained and externally triggered controlled release from these vehicles was demonstrated using a rotating Halbach magnet array, quantified via liquid chromatography, and imaged in situ using magnetic resonance imaging (MRI) and scanning electron microscopy (SEM). In the absence of the external magnetic trigger, the carnosine was found to be released from the polymer in a linear profile; however, over 50% of the drug could be released within 30 minutes of exposure to the rotating magnetic field. In addition, the release of carnosine embedded on the surface of the nano-rods was delayed if it was mixed with the iron oxide nano rods before the encapsulation. These new drug delivery vesicles have the potential to pave the way towards the safe and triggered release of onsite drug delivery, as part of a theragnostic treatment for glioblastoma.

Item Type:

Journal article

Publication Title:

Nanoscale Advances

Creators:

Habra, K., Morris, R.H., Mcardle, S.E.B. and Cave, G.W.V.

Contributors: